Table 3.
Between Groups | Low aHEI at Baseline | Medium aHEI at Baseline | High aHEI at Baseline | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tests between Intake amounts | Adj Mean Diff | SE | Cohen's d Effect sizea | pb | Adj Mean Diff | SE | Cohen's d Effect sizea | pb | Adj Mean Diff | SE | Cohen's d Effect sizea | pb |
Low flavanol intake vs Placebo | 1.251 | 1.846 | 0.148 | 0.499 | 1.673 | 2.366 | 0.198 | 0.480 | − 0.022 | 2.1 | − 0.003 | 0.992 |
Medium flavanol intake vs Placebo | 2.621 | 2.047 | 0.31 | 0.202 | 0.078 | 2.109 | 0.009 | 0.971 | 1.028 | 2.11 | 0.122 | 0.627 |
High flavanol intake vs Placebo | 5.268 | 2.085 | 0.623 | 0.012 | − 1.676 | 1.891 | − 0.198 | 0.377 | 4.355 | 2.29 | 0.515 | 0.059 |
Trend Test across intake amounts | 0.011 | 0.271 | 0.051 | |||||||||
Interaction test (aHEI vs intake amount) | F-test (6,186) = 1.87, p = 0.088 |
Bold value indicates p < 0.05.
aCohen’s d effect size calculated taking Adj Mean Diff divided by baseline measures standard deviation.
bTwo-sided p value for t-test of treatment at each intake amount compared to placebo from longitudinal mixed effects model.
Adj Mean Diff, adjusted mean difference;